Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gardasil for Recurrent Respiratory Papillomatosis in Children
NCT01995721Phase 3Unknown
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Feb 2014
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Phase 3, open-label trial of qHPV vaccine in recurrent respiratory papillomatosis (RRP), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoint: Number of papilloma relapses. Status: unknown.
02
Drugs
qHPV vaccine
03
Conditions
recurrent respiratory papillomatosis (RRP)
Beyond the preview
Go deeper on NCT01995721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01995721.